Exhaled biomarkers in lung cancer
暂无分享,去创建一个
I. Horváth | M. Kollai | Z. Lázár | G. Losonczy | I. Horváth | Z. Lázár | N. Gyulai | M. Kollai | G. Losonczy | N. Gyulai | Nóra Gyulai
[1] B. Han,et al. Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: a systematic review and meta-analysis. , 2009, European journal of cancer.
[2] K. Kostikas,et al. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer. , 2009, Lung cancer.
[3] Onofrio Resta,et al. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. , 2009, Lung cancer.
[4] E. M. Gaspar,et al. Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders. , 2009, Journal of chromatography. A.
[5] E. Brambilla,et al. Fragile histidine triad gene inactivation in lung cancer: the European Early Lung Cancer project. , 2009, American journal of respiratory and critical care medicine.
[6] Raghuraj Rao,et al. Data-driven optimization of metabolomics methods using rat liver samples. , 2009, Analytical chemistry.
[7] P. Thomas,et al. Exhaled breath analysis: novel approach for early detection of lung cancer. , 2009, Lung cancer.
[8] L. Freitag,et al. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study , 2009, Thorax.
[9] Eric Edell,et al. Detection and Localization of Intraepithelial Neoplasia and Invasive Carcinoma Using Fluorescence-Reflectance Bronchoscopy: An International, Multicenter Clinical Trial , 2009, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[10] E. Hirschowitz. Biomarkers for lung cancer screening: interpretation and implications of an early negative advanced validation study. , 2009, American journal of respiratory and critical care medicine.
[11] J. Tímár,et al. Genomics of lung cancer may change diagnosis, prognosis and therapy , 2009, Pathology & Oncology Research.
[12] Ugo Pastorino,et al. Plasma DNA quantification in lung cancer computed tomography screening: five-year results of a prospective study. , 2009, American journal of respiratory and critical care medicine.
[13] G. Corso,et al. Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy , 2008, European Respiratory Journal.
[14] T. Alonzo,et al. Molecular Cancer BioMed Central Review , 2007 .
[15] Holly Janes,et al. Pivotal Evaluation of the Accuracy of a Biomarker Used for Classification or Prediction: Standards for Study Design , 2008, Journal of the National Cancer Institute.
[16] H. Haick,et al. Detecting simulated patterns of lung cancer biomarkers by random network of single-walled carbon nanotubes coated with nonpolymeric organic materials. , 2008, Nano letters.
[17] M. Ghafar,et al. Correlation of 8‐isoprostane, interleukin‐6 and cardiac functions with clinical score in childhood obstructive sleep apnoea , 2008, Acta paediatrica.
[18] Hye-Jin Sung,et al. Biomarkers for the lung cancer diagnosis and their advances in proteomics. , 2008, BMB reports.
[19] S. Lippman,et al. Lung cancer. , 2008, The New England journal of medicine.
[20] I. Horváth,et al. Adenosine triphosphate in exhaled breath condensate of healthy subjects and patients with chronic obstructive pulmonary disease , 2008, Inflammation Research.
[21] M. Spitz,et al. An Expanded Risk Prediction Model for Lung Cancer , 2008, Cancer Prevention Research.
[22] U. Range,et al. Exhaled breath condensate nitrite--methodological problems of sample collection. , 2008, Medical science monitor : international medical journal of experimental and clinical research.
[23] Yang Xie,et al. Predicting the future for people with lung cancer , 2008, Nature Medicine.
[24] David Smith,et al. Quantification of trace levels of the potential cancer biomarkers formaldehyde, acetaldehyde and propanol in breath by SIFT-MS , 2008, Journal of breath research.
[25] Fabio Ferrari,et al. Proteomic analysis of exhaled breath condensate from single patients with pulmonary emphysema associated to alpha1-antitrypsin deficiency. , 2008, Journal of proteomics.
[26] J. Austin,et al. Detection of lung cancer using weighted digital analysis of breath biomarkers. , 2008, Clinica chimica acta; international journal of clinical chemistry.
[27] P. Mazzone,et al. Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[28] M. Páez de la Cadena,et al. How the measurements of a few serum markers can be combined to enhance their clinical values in the management of cancer. , 2008, Anticancer research.
[29] L. Jeong,et al. Inhibition of cell proliferation through cell cycle arrest and apoptosis by thio-Cl-IB-MECA, a novel A3 adenosine receptor agonist, in human lung cancer cells. , 2008, Cancer letters.
[30] Sabine Kischkel,et al. Impact of sampling procedures on the results of breath analysis , 2008, Journal of breath research.
[31] György Horvath,et al. Human Ovarian Carcinomas Detected by Specific Odor , 2008, Integrative cancer therapies.
[32] Q. Jöbsis,et al. Biomarker reproducibility in exhaled breath condensate collected with different condensers , 2008, European Respiratory Journal.
[33] Ildikó Horváth,et al. Influence of condensing equipment and temperature on exhaled breath condensate pH, total protein and leukotriene concentrations. , 2008, Respiratory medicine.
[34] N. Alexis,et al. Extracellular purines are biomarkers of neutrophilic airway inflammation , 2008, European Respiratory Journal.
[35] R. Stockley,et al. Validation of assays for inflammatory mediators in exhaled breath condensate , 2008, European Respiratory Journal.
[36] Ildikó Horváth,et al. Differential Cytokine Pattern in the Exhaled Breath of Patients with Lung Cancer , 2008, Pathology & Oncology Research.
[37] J. Jett,et al. Commentary: CT screening for lung cancer--caveat emptor. , 2008, The oncologist.
[38] I. Horváth,et al. Adenosine and adenosine receptors in the pathomechanism and treatment of respiratory diseases. , 2008, Current medicinal chemistry.
[39] I. Horváth,et al. Drinking Influences Exhaled Breath Condensate Acidity , 2008, Lung.
[40] J. Swenberg,et al. A mass spectrometric method to simultaneously measure a biomarker and dilution marker in exhaled breath condensate. , 2008, Rapid communications in mass spectrometry : RCM.
[41] A. Jemal,et al. Cancer Statistics, 2008 , 2008, CA: a cancer journal for clinicians.
[42] S. Kennedy,et al. Within- and between-person variability of exhaled breath condensate pH and NH4+ in never and current smokers. , 2008, Respiratory medicine.
[43] F. Hirsch,et al. Advances in genomic and proteomic studies of non-small-cell lung cancer: clinical and translational research perspective. , 2008, Clinical lung cancer.
[44] Xuefeng Bruce Ling. High throughput screening informatics. , 2008, Combinatorial chemistry & high throughput screening.
[45] K. Kostikas,et al. Biomarkers in the exhaled breath condensate of healthy adults: mapping the path towards reference values. , 2008, Current medicinal chemistry.
[46] Jun Ye,et al. Cavity-enhanced optical frequency comb spectroscopy: application to human breath analysis. , 2008, Optics express.
[47] M. Mishima,et al. Redox-based therapeutics for lung diseases. , 2008, Antioxidants & redox signaling.
[48] A. Paradiso,et al. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer. , 2008, American journal of respiratory and critical care medicine.
[49] M. Corradi,et al. Chromium in exhaled breath condensate and pulmonary tissue of non-small cell lung cancer patients , 2008, International archives of occupational and environmental health.
[50] M. Moss,et al. Non-invasive evaluation of pulmonary glutathione in the exhaled breath condensate of otherwise healthy alcoholics. , 2008, Respiratory medicine.
[51] Y. Hamuro,et al. Hydrogen-deuterium exchange mass spectrometry for investigation of backbone dynamics of oxidized and reduced cytochrome P450cam. , 2008, Journal of inorganic biochemistry.
[52] L. J. Myers,et al. The use of canines in the detection of human cancers. , 2008, Journal of alternative and complementary medicine.
[53] R. Effros. Metabolomics in exhaled breath condensates. , 2008, American journal of respiratory and critical care medicine.
[54] M. Travers,et al. Particulate air pollution in Irish pubs is grossly underestimated. , 2008, American journal of respiratory and critical care medicine.
[55] G. Corso,et al. Metabonomic analysis of Exhaled Breath Condensate in adults by NMR spectroscopy , 2008 .
[56] Leslie Rosenthal,et al. Pooling data when analyzing biomarkers subject to a limit of detection. , 2008, Methods in molecular biology.
[57] J. Goyette,et al. Proteomics as a Method for Early Detection of Cancer: A Review of Proteomics, Exhaled Breath Condensate, and Lung Cancer Screening , 2007, Journal of General Internal Medicine.
[58] Irina Kusmartseva,et al. Panel of serum biomarkers for the diagnosis of lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[59] David F Ransohoff,et al. How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design. , 2007, Journal of clinical epidemiology.
[60] W. Black. Computed tomography screening for lung cancer: Review of screening principles and update on current status , 2007, Cancer.
[61] T. Schettgen,et al. Simultaneous determination of 3-nitrotyrosine, tyrosine, hydroxyproline and proline in exhaled breath condensate by hydrophilic interaction liquid chromatography/electrospray ionization tandem mass spectrometry. , 2007, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[62] Peter C Gøtzsche,et al. Overstating the evidence for lung cancer screening: the International Early Lung Cancer Action Program (I-ELCAP) study. , 2007, Archives of internal medicine.
[63] J. Chorostowska-Wynimko,et al. The impact of genetic markers on the diagnosis of lung cancer: a current perspective. , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[64] A Mutti,et al. Bronchoalveolar lavage, sputum and exhaled clinically relevant inflammatory markers: values in healthy adults , 2007, European Respiratory Journal.
[65] William L. Bigbee,et al. Diagnostic Accuracy of MALDI Mass Spectrometric Analysis of Unfractionated Serum in Lung Cancer , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[66] N. Paul,et al. Lung cancer screening with low-dose computed tomography: Canadian experience. , 2007, Canadian Association of Radiologists journal = Journal l'Association canadienne des radiologistes.
[67] D. Yates,et al. Collection devices influence the constituents of exhaled breath condensate , 2007, European Respiratory Journal.
[68] Peter J Sterk,et al. An electronic nose in the discrimination of patients with asthma and controls. , 2007, The Journal of allergy and clinical immunology.
[69] D. Normolle,et al. Biomarkers for Cancer Risk, Early Detection, and Prognosis: The Validation Conundrum , 2007, Cancer Epidemiology Biomarkers & Prevention.
[70] Peter B Bach,et al. Screening for lung cancer: ACCP evidence-based clinical practice guidelines (2nd edition). , 2007, Chest.
[71] Ping Wang,et al. A study of the volatile organic compounds exhaled by lung cancer cells in vitro for breath diagnosis , 2007, Cancer.
[72] Anton Amann,et al. Lung cancer detection by proton transfer reaction mass-spectrometric analysis of human breath gas , 2007 .
[73] F. G. Río,et al. New screening method for lung cancer by detecting volatile organic compounds in breath , 2007, Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.
[74] Geoffrey J. Barton,et al. Probabilistic prediction and ranking of human protein-protein interactions , 2007, BMC Bioinformatics.
[75] Tarek Mekhail,et al. Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array , 2007, Thorax.
[76] T. Sutedja,et al. Lung cancer screening: has there been any progress? Computed tomography and autofluorescence bronchoscopy , 2007, Current opinion in pulmonary medicine.
[77] Ji Hee Ha,et al. Chemical sensing of DNT by engineered olfactory yeast strain. , 2007, Nature chemical biology.
[78] Bogusław Buszewski,et al. Human exhaled air analytics: biomarkers of diseases. , 2007, Biomedical chromatography : BMC.
[79] Károly Héberger,et al. Metabolomics applied to exhaled breath condensate in childhood asthma. , 2007, American journal of respiratory and critical care medicine.
[80] C. Henschke,et al. Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screening. , 2007, Lung cancer.
[81] George Preti,et al. Human Breath Odors and Their Use in Diagnosis , 2007, Annals of the New York Academy of Sciences.
[82] I. Horváth. Reproducibility of exhaled biomarkers in COPD—the road less traveled , 2007, International journal of chronic obstructive pulmonary disease.
[83] I. Horváth,et al. Exhaled breath condensate pH standardised for CO2 partial pressure , 2007, European Respiratory Journal.
[84] T. Schettgen,et al. Simultaneous determination of the advanced glycation end product Nɛ-carboxymethyllysine and its precursor, lysine, in exhaled breath condensate using isotope-dilution–hydrophilic-interaction liquid chromatography coupled to tandem mass spectrometry , 2007, Analytical and bioanalytical chemistry.
[85] K. Hirata,et al. Nε-(Carboxymethyl)Lysine, a Major Advanced Glycation End Product in Exhaled Breath Condensate as a Biomarker of Small Airway Involvement in Asthma , 2007, The Journal of asthma : official journal of the Association for the Care of Asthma.
[86] Erica R Thaler,et al. In Vitro Discrimination of Tumor Cell Lines with an Electronic Nose , 2005, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[87] A. Mishra,et al. The value of clinical characteristics and breast imaging studies in predicting a histopathologic diagnosis of cancer or high-risk lesion in patients with spontaneous nipple discharge. , 2007, American journal of surgery.
[88] J. Austin,et al. Prediction of lung cancer using volatile biomarkers in breath. , 2007, Cancer biomarkers : section A of Disease markers.
[89] Q. Jöbsis,et al. Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate , 2006, European Respiratory Journal.
[90] C. Mathers,et al. Projections of Global Mortality and Burden of Disease from 2002 to 2030 , 2006, PLoS medicine.
[91] O. Miettinen,et al. Survival of Patients with Stage I Lung Cancer Detected on CT Screening , 2008 .
[92] Zulfiqur Ali,et al. Data analysis for electronic nose systems , 2006 .
[93] C. Schumann,et al. Detection of Erythropoietin in Exhaled Breath Condensate of Nonhypoxic Subjects Using a Multiplex Bead Array , 2006, Mediators of inflammation.
[94] G. Gioia,et al. IL-2, TNF-α, and leptin : Local versus systemic concentrations in NSCLC patients , 2006 .
[95] Marie-Annick Persuy,et al. Quantitative assessment of olfactory receptors activity in immobilized nanosomes: a novel concept for bioelectronic nose. , 2006, Lab on a chip.
[96] B. Viollet,et al. 5′-AMP-Activated Protein Kinase (AMPK) Is Induced by Low-Oxygen and Glucose Deprivation Conditions Found in Solid-Tumor Microenvironments , 2006, Molecular and Cellular Biology.
[97] A. Kolmakov,et al. Toward the nanoscopic "electronic nose": hydrogen vs carbon monoxide discrimination with an array of individual metal oxide nano- and mesowire sensors. , 2006, Nano letters.
[98] A. Stromberg,et al. Profiling Tumor-Associated Antibodies for Early Detection of Non-small Cell Lung Cancer , 2006, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[99] J. Crusius,et al. Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy , 2006, European Respiratory Journal.
[100] I. Horváth,et al. ATS workshop proceedings: exhaled nitric oxide and nitric oxide oxidative metabolism in exhaled breath condensate. , 2006, Proceedings of the American Thoracic Society.
[101] F. Emmrich,et al. Multiplex analysis of cytokines in exhaled breath condensate , 2006, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[102] M. Mcculloch,et al. Diagnostic Accuracy of Canine Scent Detection in Early- and Late-Stage Lung and Breast Cancers , 2006, Integrative cancer therapies.
[103] L. Mariani,et al. Methylation profile in tumor and sputum samples of lung cancer patients detected by spiral computed tomography: A nested case–control study , 2006, International journal of cancer.
[104] M J Padgett,et al. Application of laser spectroscopy for measurement of exhaled ethane in patients with lung cancer. , 2006, Respiratory medicine.
[105] B. H. Patterson,et al. Evaluating markers for the early detection of cancer: overview of study designs and methods , 2006, Clinical trials.
[106] Bradford G. Stone,et al. Effect of regulating cholesterol biosynthesis on breath isoprene excretion in men , 1993, Lipids.
[107] M. Hallman,et al. Determination of ethane and pentane in free oxygen radical-induced lipid peroxidation , 1989, Lipids.
[108] S. Balseiro,et al. Is olfactory detection of human cancer by dogs based on major histocompatibility complex-dependent odour components?--A possible cure and a precocious diagnosis of cancer. , 2006, Medical hypotheses.
[109] P. Montuschi,et al. Induced sputum, exhaled breath condensate and nasal lavage fluid in electroplating workers exposed to chromium. , 2006, International journal of immunopathology and pharmacology.
[110] I. D'Agnano,et al. c-MYC deregulation is involved in melphalan resistance of multiple myeloma: role of PDGF-BB. , 2006, International journal of immunopathology and pharmacology.
[111] N. Waugh,et al. The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews. , 2006, Health technology assessment.
[112] B. Morrissey,et al. L-arginine supplementation enhances exhaled NO, breath condensate VEGF, and headache at 4,342 m. , 2005, High altitude medicine & biology.
[113] A. Paradiso,et al. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer. , 2005, American journal of respiratory and critical care medicine.
[114] R. Dweik,et al. Abnormalities in nitric oxide and its derivatives in lung cancer. , 2005, American journal of respiratory and critical care medicine.
[115] P. J. Barnes,et al. Exhaled breath condensate: methodological recommendations and unresolved questions , 2005, European Respiratory Journal.
[116] I. Horváth,et al. Comparative measurement of thromboxane A2 metabolites in exhaled breath condensate by different immunoassays , 2005, Inflammation Research.
[117] Wei Zhang,et al. Application of serum SELDI proteomic patterns in diagnosis of lung cancer , 2005, BMC Cancer.
[118] L. Bianchi,et al. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study , 2005, Respiratory research.
[119] P. Mazzone,et al. Detection of lung cancer by sensor array analyses of exhaled breath. , 2005, American journal of respiratory and critical care medicine.
[120] G. Wong,et al. Analysis of Growth Factors and Inflammatory Cytokines in Exhaled Breath Condensate from Asthmatic Children , 2005, International Archives of Allergy and Immunology.
[121] Christian Gluud,et al. Evidence based diagnostics , 2005, BMJ : British Medical Journal.
[122] I. Horváth. The exhaled biomarker puzzle: bacteria play their card in the exhaled nitric oxide–exhaled breath condensate nitrite game , 2005, Thorax.
[123] E. Weitzberg,et al. Origin of nitrite and nitrate in nasal and exhaled breath condensate and relation to nitric oxide formation , 2005, Thorax.
[124] Ping Wang,et al. A Non-invasive Detection of Lung Cancer Combined Virtual Gas Sensors Array with Imaging Recognition Technique , 2005, 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference.
[125] S. Szefler,et al. The Aerocrine exhaled nitric oxide monitoring system NIOX is cleared by the US Food and Drug Administration for monitoring therapy in asthma. , 2004, The Journal of allergy and clinical immunology.
[126] Ross Prentice,et al. Research issues and strategies for genomic and proteomic biomarker discovery and validation: a statistical perspective. , 2004, Pharmacogenomics.
[127] W. Miekisch,et al. Diagnostic potential of breath analysis--focus on volatile organic compounds. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[128] F. Stanzel,et al. Fluorescent bronchoscopy: contribution for lung cancer screening? , 2004, Lung cancer.
[129] M. Phillips,et al. Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study). , 2004, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[130] I. Rahman,et al. Non-invasive biomarkers of oxidative stress: reproducibility and methodological issues , 2004, Redox report : communications in free radical research.
[131] O. Resta,et al. Endothelin-1 Is Increased in the Breath Condensate of Patients with Non-Small-Cell Lung Cancer , 2004, Oncology.
[132] H. Kuhn,et al. Detection of p53 gene mutations in exhaled breath condensate of non-small cell lung cancer patients. , 2004, Lung cancer.
[133] W. Heindel,et al. Screening for early lung cancer with low-dose spiral computed tomography: results of annual follow-up examinations in asymptomatic smokers , 2004, European Radiology.
[134] I. Rahman,et al. ReviewBiomarkers in Breath Condensate: A promising New Non-invasive Technique in Free Radical Research , 2003, Free radical research.
[135] P. Montuschi,et al. Validation of 8-isoprostane and prostaglandin E2 measurements in exhaled breath condensate , 2003, Inflammation Research.
[136] J. Knottnerus,et al. Assessment of the accuracy of diagnostic tests: the cross-sectional study. , 2003, Journal of clinical epidemiology.
[137] E. Martinelli,et al. Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. , 2003, Biosensors & bioelectronics.
[138] F. Fazio,et al. Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers: 2-year results , 2003, The Lancet.
[139] C. Henschke,et al. The cost-effectiveness of low-dose CT screening for lung cancer: preliminary results of baseline screening. , 2003, Chest.
[140] T. Mitsui,et al. Inadequacy of theoretical basis of breath methylated alkane contour for assessing oxidative stress. , 2003, Clinica chimica acta; international journal of clinical chemistry.
[141] M. Phillips,et al. Response: scientific basis of the breath methylated alkane contour , 2003 .
[142] M. Gaub,et al. Plasma DNA microsatellite panel as sensitive and tumor‐specific marker in lung cancer patients , 2003, International journal of cancer.
[143] Kevin Gleeson,et al. Detection of lung cancer with volatile markers in the breath. , 2003, Chest.
[144] M. Corradi,et al. Aldehydes in exhaled breath condensate of patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[145] David Smith,et al. Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry. , 2003, Rapid communications in mass spectrometry : RCM.
[146] I. Horváth,et al. Comparison of nasal and oral inhalation during exhaled breath condensate collection. , 2003, American journal of respiratory and critical care medicine.
[147] David Moher,et al. The STARD Statement for Reporting Studies of Diagnostic Accuracy: Explanation and Elaboration , 2003, Annals of Internal Medicine [serial online].
[148] S. Lantuejoul,et al. Early detection of lung cancer: role of biomarkers , 2003, European Respiratory Journal.
[149] M. Phillips,et al. Effect of oxygen on breath markers of oxidative stress , 2003, European Respiratory Journal.
[150] Robert A. Smith,et al. American Cancer Society Guidelines for the Early Detection of Cancer, 2003 , 2003, CA: a cancer journal for clinicians.
[151] Peter B Bach,et al. Screening for lung cancer: the guidelines. , 2003, Chest.
[152] I. Horváth,et al. Adenosine in exhaled breath condensate in healthy volunteers and in patients with asthma , 2002, European Respiratory Journal.
[153] P. Barnes,et al. Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. , 2002, Chest.
[154] Hajime Nakata,et al. Lung cancer screening using low-dose spiral CT: results of baseline and 1-year follow-up studies. , 2002, Chest.
[155] I. Hernández-Aguado,et al. The winding road towards evidence based diagnoses , 2002, Journal of epidemiology and community health.
[156] A. Nagy,et al. A new method for the simultaneous measurement of aerosol particle size, complex refractive index and particle density , 2002 .
[157] M. Gare,et al. Dilution of respiratory solutes in exhaled condensates. , 2002, American journal of respiratory and critical care medicine.
[158] J André Knottnerus,et al. Evaluation of diagnostic procedures , 2002, BMJ : British Medical Journal.
[159] Elizabeth Erwin,et al. Expression and activity of pH-regulatory glutaminase in the human airway epithelium. , 2002, American journal of respiratory and critical care medicine.
[160] O. Resta,et al. Interleukin-6 is increased in breath condensate of patients with non-small cell lung cancer. , 2002, The International journal of biological markers.
[161] Patrick C. Walsh,et al. American Cancer Society guidelines for the early detection of cancer. , 2002, CA: a cancer journal for clinicians.
[162] H. Wirtz,et al. Factors influencing breath condensate volume , 2001, Pneumologie.
[163] I. Horváth,et al. "Haemoxygenase-1 induction and exhaled markers of oxidative stress in lung diseases", summary of the ERS Research Seminar in Budapest, Hungary, September, 1999. , 2001, The European respiratory journal.
[164] M S Pepe,et al. Phases of biomarker development for early detection of cancer. , 2001, Journal of the National Cancer Institute.
[165] H. Rammensee,et al. “Electronic nose” detects major histocompatibility complex-dependent prerenal and postrenal odor components , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[166] Y. Yoshioka,et al. Influence of thoracic radiotherapy on exhaled nitric oxide levels in patients with lung cancer. , 2001, Japanese journal of clinical oncology.
[167] S. Sone,et al. Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner , 2001, British Journal of Cancer.
[168] I. Horváth,et al. Heme oxygenase-1 induction and exhaled markers of oxidative stress in lung diseases , 2001 .
[169] Murat O. Balaban,et al. Transportability of data between electronic noses: mathematical methods , 2000 .
[170] F. Haas,et al. Oxidative stress after lung resection therapy: A pilot study. , 2000, Chest.
[171] O. Miettinen,et al. Early Lung Cancer Action Project: overall design and findings from baseline screening , 1999, The Lancet.
[172] M. Phillips,et al. Variation in volatile organic compounds in the breath of normal humans. , 1999, Journal of chromatography. B, Biomedical sciences and applications.
[173] R. Cataneo,et al. Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study , 1999, The Lancet.
[174] P. Barnes,et al. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress , 1998, Thorax.
[175] H. Kuo,et al. Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer. , 1998, British Journal of Cancer.
[176] C. Gessner. [Detection of mutations of the K-ras gene in condensed breath of patients with non-small-cell lung carcinoma (NSCLC) as a possible noninvasive screening method]. , 1998, Pneumologie.
[177] C. Mountain,et al. Revisions in the International System for Staging Lung Cancer. , 1997, Chest.
[178] M. Phillips. Method for the collection and assay of volatile organic compounds in breath. , 1997, Analytical biochemistry.
[179] J. Mulshine,et al. Molecular markers in early cancer detection. New screening tools. , 1995, Chest.
[180] H. Hämmerle,et al. Detection of nonvolatile macromolecules in breath. A possible diagnostic tool? , 1993, The American review of respiratory disease.
[181] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.
[182] HywelC. Williams,et al. SNIFFER DOGS IN THE MELANOMA CLINIC? , 1989, The Lancet.
[183] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.
[184] H. J. O’neill,et al. A computerized classification technique for screening for the presence of breath biomarkers in lung cancer. , 1988, Clinical chemistry.
[185] G. Preti,et al. Analysis of lung air from patients with bronchogenic carcinoma and controls using gas chromatography-mass spectrometry. , 1988, Journal of chromatography.
[186] H. J. O’neill,et al. Volatile organic compounds in exhaled air from patients with lung cancer. , 1985, Clinical chemistry.
[187] A. B. Robinson,et al. Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. , 1971, Proceedings of the National Academy of Sciences of the United States of America.